GASTROENTEROLOGY INFORMATION CENTER

News

Topline Data Announced for Selonsertib in Patients With Compensated Cirrhosis Due to NASH

Topline Data Announced for Selonsertib in Patients With Compensated Cirrhosis Due to NASH

Topline data from the Phase 3 STELLAR-4 trial showed that selonsertib, an investigational treatment for patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH), was not associated with a significant improvement in fibrosis without worsening of NASH.

Assessing the Outcome of a Colorectal Cancer Screening Outreach Strategy in Primary Care

After primary care patients received invitations in the mail for colorectal cancer screening by fecal immunochemical testing or colonoscopy, results show that more patients invited to screen for colonoscopy switched to FIT.

DocuSol Kids Available OTC for Children With General Constipation

Each DocuSol Kids mini-enema (5mL) contains a delivered dose of docusate sodium 100mg in a polyethylene glycol base.

Opinion

Bowel Preparation for Colorectal Cancer Screening: Improving Outcomes

Stool burden can be a particularly challenging aspect of colonoscopies, making potentially cancerous lesions easier to miss.

Acute abdominal pain, fever may signify diverticulitis

In older patients who complain of fever and lower abdominal pain, consider diverticulitis, especially if the patient has a previous diagnosis of diverticulosis.

Features

Opioid-Induced Constipation: Insights Into Diagnosis and Effective Treatment

Opioid-Induced Constipation: Insights Into Diagnosis and Effective Treatment

Conventional approaches to treatment of opioid-induced constipation include the use of treatment modalities that address non-opioid-related constipation as well as new medications that target the OIC mechanism of action.

Fecal Transplant in Managing Immune Checkpoint Inhibitor-Associated Colitis

Fecal Transplant in Managing Immune Checkpoint Inhibitor-Associated Colitis

Transplanting fecal bacteria from healthy donors might prove to be effective in resolving cancer immunotherapy-triggered colitis, a pair of case reports has suggested.

Sign Up for Free e-newsletters